Overview
Sundhar Ramalingam is an Oncologist in Durham, North Carolina. Dr. Ramalingam is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Clear Cell Sarcoma. Dr. Ramalingam is currently accepting new patients.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
40 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Health Integrated Practice Inc
Harry Erba is an Oncologist and a Hematologist in Durham, North Carolina. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is currently accepting new patients.
The Moses H Cone Memorial Hospital Operating Corporation
Peter Ennever is a Hematologist Oncology specialist and a Hematologist in High Point, North Carolina. Dr. Ennever is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Antiphospholipid Syndrome, Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Myelodysplastic Syndrome (MDS). Dr. Ennever is currently accepting new patients.
Duke Health Integrated Practice Inc
Carlos Decastro is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Decastro is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Decastro is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Ramalingam isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Ramalingam isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Ramalingam isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Ramalingam isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Ramalingam isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Ramalingam isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Ramalingam isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Ramalingam isAdvanced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Ramalingam isAdvanced. Learn about Choriocarcinoma.
- Chronic T-Cell Leukemia (CTCL)Dr. Ramalingam isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Large-Cell Immunoblastic LymphomaDr. Ramalingam isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Lung CancerDr. Ramalingam isAdvanced. Learn about Lung Cancer.
- Experienced
- AgranulocytosisDr. Ramalingam isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ramalingam isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Appendix CancerDr. Ramalingam isExperienced. Learn about Appendix Cancer.
- AstrocytomaDr. Ramalingam isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Ramalingam isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- B-Cell LymphomaDr. Ramalingam isExperienced. Learn about B-Cell Lymphoma.
